Status:
RECRUITING
Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
Lead Sponsor:
University of Leipzig
Conditions:
Acute Coronary Syndrome
Prevention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and wor...
Detailed Description
In this randomized study, the investigators aim to investigate whether additional self-monitoring of cholesterol values by patients leads to more effective LDL reduction and quicker achievement of the...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value
- Signed informed consent
Exclusion
- Persons unable to understand the study
- Persons unable or unwilling to perform self-measurements
- Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target
- Pre-menopausal women without contraception
- Use of experimental drugs or investigational products within 30 days prior to screening
- Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06526013
Start Date
June 1 2024
End Date
September 30 2025
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic of cardiology University clinic Leipzig
Leipzig, Saxony, Germany, 04103